Kronos Bio Inc.

NASDAQ: KRON · Real-Time Price · USD
0.88
0.01 (1.49%)
At close: Jun 20, 2025, 9:43 AM

Kronos Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.86M 2.27M 2.37M 2.69M 2.52M 2.29M 917K 1.86M 1.22M n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a 478K 510K 1.18M 1.15M 1.14M 1.15M 1.14M 1.09M 1.16M 898K 1.11M 905K
Gross Profit
1.86M 2.27M 2.37M 2.69M 2.52M 1.81M 407K 685K 67K -1.14M -1.15M -1.14M -1.09M -1.16M -898K -1.11M -905K
Operating Income
-9.44M -27.15M -15.72M -18.02M -19.21M -27.34M -33.83M -32.17M -28.49M -33.68M -33.54M -33.53M -36.37M -62.41M -33.67M -29.14M -26.18M
Interest Income
1.08M 1.34M 1.61M 1.82M 2.04M 2.02M 2.45M 2.43M 2.25M 1.9M 1.28M 627K 102K 72K 70K 86K 92K
Pretax Income
-8.36M -25.81M -14.11M -16.2M -29.96M -25.32M -31.37M -29.74M -26.24M -31.78M -32.26M -32.9M -36.26M -62.33M -33.6M -29.05M -26.09M
Net Income
-8.36M -25.81M -14.11M -16.2M -29.96M -25.32M -31.37M -29.74M -23.41M -29.15M -30.97M -32.28M -36.16M -62.33M -33.6M -29.05M -26.09M
Selling & General & Admin
6.12M 4.92M 5.82M 6.37M 7.51M 10.93M 9.4M 11.36M 10.06M 10.51M 10.13M 10.82M 11.93M 11.59M 8.98M 9.34M 8.58M
Research & Development
2.12M 8.41M 12.27M 13.77M 14.22M 18.23M 25.34M 22.67M 19.66M 23.17M 23.4M 22.71M 24.44M 50.82M 24.69M 19.8M 17.59M
Other Expenses
3.07M 16.09M n/a 578K 12.79M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
11.31M 29.42M 18.09M 20.71M 34.51M 29.15M 34.74M 34.03M 29.71M 33.68M 33.54M 33.53M 36.37M 62.41M 33.67M 29.14M 26.18M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
11.31M 29.42M 18.09M 20.71M 34.51M 29.63M 34.74M 34.03M 29.71M 33.68M 33.54M 33.53M 36.37M 62.41M 33.67M 29.14M 26.18M
Income Tax Expense
n/a n/a n/a n/a 1.23M n/a n/a n/a -2.82M -2.63M -1.28M -627K -102K -474K 70K 86K 92K
Shares Outstanding (Basic)
60.81M 60.34M 60.31M 60.1M 59.52M 58.27M 58.15M 57.4M 57.15M 56.52M 56.32M 56.12M 55.84M 55.36M 54.98M 54.51M 54.15M
Shares Outstanding (Diluted)
60.81M 60.34M 60.31M 60.1M 59.52M 58.27M 58.15M 57.4M 57.15M 56.52M 56.32M 56.12M 55.84M 55.36M 54.98M 54.51M 54.15M
EPS (Basic)
-0.14 -0.43 -0.23 -0.27 -0.5 -0.43 -0.54 -0.52 -0.41 -0.52 -0.55 -0.58 -0.65 -1.13 -0.61 -0.53 -0.48
EPS (Diluted)
-0.14 -0.43 -0.23 -0.27 -0.5 -0.43 -0.54 -0.52 -0.41 -0.52 -0.55 -0.58 -0.65 -1.13 -0.61 -0.53 -0.48
EBITDA
-6.15M -10.65M -15.3M -17.02M -18.73M -24.84M -33.31M -28.56M -27.92M -33.11M -32.97M -32.97M -35.81M -61.17M -33.15M -28.68M -25.73M
EBIT
-6.37M -11.06M -15.72M -17.45M -19.21M -27.34M -33.83M -29.25M -28.49M -33.68M -33.54M -33.53M -36.37M -62.33M -33.67M -29.14M -26.18M
Depreciation & Amortization
220K 409K 412K 420K 1.27M 478K 510K 1.18M 1.15M 1.14M 1.15M 1.14M 1.09M 1.16M 898K 1.11M 905K